|
|
Article: Introduction of generic Claritin will reduce antihistamine market.(loratadine from Schering-Plough)
- Article from:
- Immunotherapy Weekly
- Article date:
- October 2, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 OCT 2 - (NewsRx.com & NewsRx.net) -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announced that the introduction of generic forms of Claritin (Schering-Plough's loratadine) will reduce the United States antihistamine market by 15% over the next 10 years.
According to the new report entitled Allergic Rhinitis, the availability of over-the-counter nonsedating antihistamines will reduce the prescription drug-treated population in the U.S. from 95% of the diagnosed cases in 2001 to 80% in 2011.
"The historically lucrative allergic rhinitis market is on the verge of major ...